Last reviewed · How we verify
Vancomycin Continuous Infusion
Vancomycin Continuous Infusion is a Small molecule drug developed by Aaron Cook. It is currently FDA-approved. Also known as: Vancocin, Continuous infusion.
Vancomycin is a small molecule inhibitor of peptidoglycan, classified as an INHIBITOR drug class. It is used to treat Gram-Positive Bacterial Infections, among other conditions, and has been studied in clinical trials for its effects on kidney function and other conditions such as sepsis and bacterial meningitis.
At a glance
| Generic name | Vancomycin Continuous Infusion |
|---|---|
| Also known as | Vancocin, Continuous infusion |
| Sponsor | Aaron Cook |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis (NA)
- Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention (PHASE1)
- FMT for Lung and Associated-organ Rescue Efficacy in Pulmonary Infection With MDROs (NA)
- Continuous vs. Intermittent Infusion Vancomycin (PHASE4)
- A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients (PHASE1)
- A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis (PHASE3)
- Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin (PHASE4)
- Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vancomycin Continuous Infusion CI brief — competitive landscape report
- Vancomycin Continuous Infusion updates RSS · CI watch RSS
- Aaron Cook portfolio CI
Frequently asked questions about Vancomycin Continuous Infusion
What is Vancomycin Continuous Infusion?
Who makes Vancomycin Continuous Infusion?
Is Vancomycin Continuous Infusion also known as anything else?
What development phase is Vancomycin Continuous Infusion in?
Related
- Manufacturer: Aaron Cook — full pipeline
- Also known as: Vancocin, Continuous infusion
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing